Understanding 46,XX Ovarian Dysgenesis-Short Stature Syndrome: A Genetic Insight
Explore the benefits of genetic testing for 46,XX ovarian dysgenesis-short stature syndrome, including early diagnosis, personalized treatment, and family planning.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Genetic Testing: A Gateway to Understanding 46,XY Sex Reversal 9
Explore how genetic testing aids in diagnosing 46,XY sex reversal 9, enables early intervention, personalized treatments, and supports family planning decisions.
ACTH-Independent Macronodular Adrenal Hyperplasia 2: Unraveling the Genetic Threads
Genetic testing for AIMAH2 enhances diagnosis and personalized treatment by identifying PDE11A gene mutations, offering new insights for managing adrenal hyperplasia.
Assessing Adams-Oliver Syndrome 5: The Role of Genetic Testing in Unraveling Complexities
Uncover the role of genetic testing in diagnosing Adams-Oliver Syndrome 5, highlighting personalized treatment, family planning, and the ARHGAP31 gene variant.
Advancements in Amelogenesis Imperfecta Type 1H: The Role of Genetic Testing
Explore how genetic testing enhances diagnosis and treatment of Amelogenesis Imperfecta Type 1H, focusing on the RELT gene mutation and personalized care strategies.
Amyotrophic Lateral Sclerosis Type 22: Harnessing Genetic Testing for a Brighter Future
Explore ALS Type 22 advancements with genetic testing. Identify mutations, enhance diagnosis, guide treatments, and offer hope in managing this neurodegenerative disease.
Aortic Aneurysm, Familial Thoracic 9: Genetic Insights for Better Outcomes
Explore how genetic testing transforms the management of Aortic Aneurysm, Familial Thoracic 9, offering early detection, personalized care, and improved outcomes.
Decoding the Complexities: Genetic Testing for Ataxia - Intellectual Disability - Oculomotor Apraxia - Cerebellar Cysts Syndrome
Unlock better care for AIDOA-CCS with genetic testing insights. Discover early diagnosis, personalized treatments, and family planning guidance for this rare syndrome.